A comprehensivein silicoexploration of pharmacological properties, bioactivities and COX-2 inhibitory potential of eleutheroside B fromEleutherococcus senticosus(Rupr. & Maxim.) Maxim.

被引:25
作者
Ahmed, Sium [1 ]
Moni, Dil Afroj [1 ]
Sonawane, Kailas Dashrath [2 ,3 ]
Paek, Kee Yoeup [4 ]
Shohael, Abdullah Mohammad [1 ]
机构
[1] Jahangirnagar Univ, Cell Genet & Plant Biotechnol Lab, Dept Biotechnol & Genet Engn, Savar, Bangladesh
[2] Shivaji Univ, Dept Microbiol, Kolhapur, Maharashtra, India
[3] Shivaji Univ, Struct Bioinformat Unit, Dept Biochem, Kolhapur, Maharashtra, India
[4] Chungbuk Natl Univ, Res Ctr Dev Adv Hort Technol, Cheongju, South Korea
关键词
Anti-inflammatory; COX-2; drug discovery; Eleutheroside B; structural bioinformatics; IN-SILICO; ELEUTHEROCOCCUS-SENTICOSUS; SOMATIC EMBRYOS; MOLECULAR DOCKING; DRUG DISCOVERY; ANTIOXIDANT; DERIVATIVES; METABOLISM; TOXICITY; SIMULATION;
D O I
10.1080/07391102.2020.1803135
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eleutherococcus senticosus(Rupr. & Maxim.) Maxim., popularly known as 'Siberian ginseng', is an important medicinal plant. Pharmacologically active compounds of this plant are called eleutherosides and among them, eleutheroside B is the most prevalent. TheE. senticosushas been reported to have many medicinal properties however; very few studies are reported to understand the medicinal properties of eleutheroside B. Consequently, in the present study various computational tools have been used to predict the drug-likeness, bioactivities, and pharmacokinetic properties of eleutheroside B. Besides, the inhibitory potential of eleutheroside B has been investigated against cyclooxygenase 2 (COX-2) enzyme. This study suggests that eleutheroside B is a drug-like compound with bioactivity score (-0.08 to 0.38), having satisfactory pharmacokinetic values. Metabolism and toxicities were further studied using FAME3, GLORY, pred-hERG and Endocrine Disruptome tools. No severe toxicities (Ames, hepatotoxicity, cardiotoxicity, skin sensitization) were predicted. Rat acute toxicity, ecotoxicity and cell line cytotoxicity were evaluated based on GUSAR and CLC-pred. The compound has been predicted as non-toxic (class 5), non-hERG inhibitor and less likely to cause adverse drug interactions. Molecular docking against COX-2 enzyme revealed strong hydrogen bonds (SER530, TYR355, LEU352, SER353, VAL349, TYR385, MET522) and hydrophobic interaction (LEU352) with eleutheroside B. The docking score (-6.97 kcal/mol) suggested that this molecule can be utilized as an anti-inflammatory agent as well as a potential anticancer drug in the future. Hence, this is a comprehensive integratedin silicoapproach to establish the anti-inflammatory mechanism of eleutheroside B in the background of its potential in future drug development. Communicated by Ramaswamy H. Sarma
引用
收藏
页码:6553 / 6566
页数:14
相关论文
共 77 条
[1]  
Ahmed S., 2019, PHARMACOLOGYONLINE, V2
[2]  
Alodeani Essa Ajmi, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P676, DOI 10.1016/j.apjtb.2015.04.010
[3]   Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies [J].
Aziz, Nur ;
Kim, Mi-Yeon ;
Cho, Jae Youl .
JOURNAL OF ETHNOPHARMACOLOGY, 2018, 225 :342-358
[4]   Simulated Interactions between Endothelin Converting Enzyme and Aβ Peptide: Insights into Subsite Recognition and Cleavage Mechanism [J].
Barage, Sagar H. ;
Jalkute, Chidambar B. ;
Dhanavade, Maruti J. ;
Sonawane, Kailas D. .
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2014, 20 (04) :409-420
[5]   Molecular Insights into Destabilization of Alzheimer's Aβ Protofibril by Arginine Containing Short Peptides: A Molecular Modeling Approach [J].
Barale, Sagar S. ;
Parulekar, Rishikesh S. ;
Fandilolu, Prayagraj M. ;
Dhanavade, Maruti J. ;
Sonawane, Kailas D. .
ACS OMEGA, 2019, 4 (01) :892-903
[6]  
Berezovskaya I.V., 2003, Pharm. Chem. J, V37, P139, DOI [10.1023/A:1024586630954, DOI 10.1023/A:1024586630954]
[7]   Natural products for human health: an historical overview of the drug discovery approaches [J].
Bernardini, S. ;
Tiezzi, A. ;
Masci, V. Laghezza ;
Ovidi, E. .
NATURAL PRODUCT RESEARCH, 2018, 32 (16) :1926-1950
[8]   Structural and functional basis of cyclooxygenase inhibition [J].
Blobaum, Anna L. ;
Marnett, Lawrence J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) :1425-1441
[9]   Pred-hERG: A Novel web-Accessible Computational Tool for Predicting Cardiac Toxicity [J].
Braga, Rodolpho C. ;
Alves, Vinicius M. ;
Silva, Meryck F. B. ;
Muratov, Eugene ;
Fourches, Denis ;
Liao, Luciano M. ;
Tropsha, Alexander ;
Andrade, Carolina H. .
MOLECULAR INFORMATICS, 2015, 34 (10) :698-701
[10]   Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy [J].
Cannavo, Alessandro ;
Liccardo, Daniela ;
Koch, Walter J. .
FRONTIERS IN PHYSIOLOGY, 2013, 4